Cancer Research Fund of the Damon Runyon-walter Winchell Foundation is a 501(c)(3) organization based in New York, New York, registered in 1947, with $54,683,607 in FY2024 revenue. CharityIndex grades it B.
Revenue (FY2024)
$54.7M
▲ 179.6% vs prior year
Health median: $840K
Expenses (FY2024)
$25.1M
Net assets
$134.9M
Employees
—
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for Cancer Research Fund of the Damon Runyon-walter Winchell Foundation— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Cancer Research Fund of the Damon Runyon-walter Winchell Foundation: 65 mo reserves · +54% margin earns a B+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. Not scored for Cancer Research Fund of the Damon Runyon-walter Winchell Foundation— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Cancer Research Fund of the Damon Runyon-walter Winchell Foundation: 2 of 5 disclosure signals earns a C on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Revenue grew from $16.7M (FY2013) to $54.7M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
54.2%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$170.4M
Total liabilities
$35.5M
Net assets
$134.9M
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $54,683,607▲180% | $25,059,618▼1.4% | $134,853,977▲7.6% | $170,380,475▲6.1% | 990 |
| 2023 | $19,559,693▲24.5% | $25,408,684▲19.7% | $125,306,335▲9.2% | $160,511,709▲8.7% | 990 |
| 2022 | $15,715,675▲9.2% | $21,219,216▼1.7% | $114,759,715▲2.8% | $147,680,687▲2.9% | 990 |
| 2021 | $14,385,319▼30.0% | $21,596,927▲6.1% | $111,641,431▼21.9% | $143,543,813▼18.2% | 990 |
| 2020 | $20,562,891▼62.1% | $20,352,745▼12.8% | $143,018,485▲27.0% | $175,580,654▲18.5% | 990 |
| 2019 | $54,248,600▲158% | $23,330,168▼7.8% | $112,585,245▼2.1% | $148,107,071▼1.6% | 990 |
| 2018 | $21,005,283▼2.6% | $25,301,097▲19.3% | $115,018,044▼1.2% | $150,535,887▲1.2% | 990 |
| 2017 | $21,568,069▲30.3% | $21,204,617▲8.2% | $116,471,765▲3.8% | $148,707,992▲4.4% | 990 |
| 2016 | $16,558,922▲35.2% | $19,596,662▼8.7% | $112,155,650▲6.0% | $142,411,870▲5.0% | 990 |
| 2015 | $12,244,257▼53.0% | $21,463,588▲21.0% | $105,830,243▼11.4% | $135,646,786▼6.7% | 990 |
| 2014 | $26,078,820▲56.1% | $17,742,894▼14.5% | $119,510,832▲7.0% | $145,440,975▲5.1% | 990 |
| 2013 | $16,701,430 | $20,748,562▲29.5% | $111,729,179▲8.9% | $138,320,610▲11.7% | 990 |
| 2012 | — | $16,017,503▲5.1% | $102,574,751▲17.0% | $123,856,034▲15.6% | 990 |
| 2011 | — | $15,244,420▲31.6% | $87,638,038▲14.2% | $107,113,018▲16.1% | 990 |
| 2009 | — | $11,583,889 | $76,743,768 | $92,257,373 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
114 grants to Cancer Research Fund of the Damon Runyon-walter Winchell Foundation totaling $14.3M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| The Mark Foundation For Cancer Research Us Ltd | Research | 2024 | $413,436 |
| St Louis Community Foundation Incorporated | Support the medical research projects of nathon singh at washinton university | 2024 | $200,000 |
| American Endowment Foundation | Medical research | 2024 | $101,300 |
| American Online Giving Foundation Inc | General support | 2024 | $28,141 |
| Gs Donor Advised Philanthropy Fund For Wealth Management Inc | Medical / public services | 2024 | $21,000 |
| Silicon Valley Community Foundation | Health | 2024 | $15,000 |
| Biotechnology Innovation Organization | Sponsorship | 2024 | $10,000 |
| Amalgamated Charitable Foundation Inc | General operating support | 2024 | $10,000 |
| Charities Aid Foundation America | Charitable donation | 2024 | $7,587 |
| The Us Charitable Gift Trust | For recipient's exempt purpose | 2024 | $6,000 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $375,746 |
| The Mark Foundation For Cancer Research Us Ltd | Research | 2023 | $306,316 |
| St Louis Community Foundation Incorporated | Medical research at washington university, july 1, 2023 through june 30, 2024 for the project(s) of nathan singh, md - damon runyon clinical investigator. 100% of the grant is to be allocated to the research and not to washington university overhead | 2023 | $200,000 |
| Donor Advised Charitable Giving | Health | 2023 | $120,825 |
| American Online Giving Foundation Inc | General support | 2023 | $62,979 |
Explore more
Data for Cancer Research Fund of the Damon Runyon-walter Winchell Foundation (EIN 13-1933825) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.